Upgrade to SI Premium - Free Trial

BioNTech (BNTX) PT Lowered to $128 at BMO Capital

March 11, 2026 9:15 AM
BMO Capital analyst Evan David Seigerman lowered the price target on BioNTech (NASDAQ: BNTX) to $128.00 (from $143.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change